JOSE PENA: Open Payments
NPI 1407346927 · FORT COLLINS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$354 in 13 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $171 · 2025 $354
Food & beverage: $354
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $117 |
| Alkermes, Inc. | 6 | $114 |
| ABBVIE INC. | 3 | $67 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: CAPLYTA, ARISTADA, MAVYRET, UZEDY, VIVITROL, COBENFY, REXULTI.
Industry payments across CO — which companies pay providers there.
